Form 8-K - Current report:
SEC Accession No. 0001558370-25-007744
Filing Date
2025-05-14
Accepted
2025-05-14 16:06:21
Documents
16
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20250514x8k.htm   iXBRL 8-K 30570
2 EX-99.1 ganx-20250514xex99d1.htm EX-99.1 149259
3 GRAPHIC ganx-20250514xex99d1001.jpg GRAPHIC 5710
  Complete submission text file 0001558370-25-007744.txt   331069

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20250514.xsd EX-101.SCH 4032
5 EX-101.DEF ganx-20250514_def.xml EX-101.DEF 2827
6 EX-101.LAB ganx-20250514_lab.xml EX-101.LAB 17908
7 EX-101.PRE ganx-20250514_pre.xml EX-101.PRE 10619
18 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20250514x8k_htm.xml XML 5028
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 25945387
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)